Evidence map›Paper›PMID 29740453›Full record

ReviewFrontiers in immunology2018

Deoxyribonucleic Acid Methylation in Systemic Lupus Erythematosus: Implications for Future Clinical Practice.

Emma Weeding, Amr H Sawalha

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. UnravelingFrontiers in oncology · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. T Cells in Systemic Lupus Erythematosus.Rheumatic diseases clinics of North America · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Genetics of Antiphospholipid Syndrome.Current rheumatology reports · 2019
    Review
  18. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.Arthritis & rheumatology (Hoboken, N.J.) · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Emma WeedingDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Amr H SawalhaDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
University of Michigan–Ann Arbor · US

Funding

Role of DNA methylation in lupusR01AI097134 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Amr H Sawalha · 2013 to 2026
$4.5M
KIR+CD11ahiCD4+ T cells in Systemic AutoimmunityU19AI110502 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RICHARDSON, BRUCE C. · 2014 to 2018
$2.6M
NIAID NIH HHS R01 AI097134NIAID NIH HHS U19 AI110502
6 · The paper itself

Abstract

Differential deoxyribonucleic acid (DNA) methylation has emerged as a critical feature of systemic lupus erythematosus (SLE). Genome-wide DNA methylation studies have revealed methylation patterns characteristic of SLE-in particular, robust hypomethylation of interferon-regulated genes is a prominent finding in all cells of the immune system studied to date. These patterns reliably distinguish individuals with SLE from healthy controls and from individuals with other autoimmune diseases. For example, hypomethylation within

Indexed as

DNA MethylationEnhancer of Zeste Homolog 2 ProteinEpigenesis, GeneticGene Expression RegulationGenome-Wide Association StudyHumansImmunosuppressive AgentsImmunotherapyLupus Erythematosus, SystemicT-LymphocytesEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanImmunosuppressive AgentsautoimmunitybiomarkerEZH2IFI44LlupusmethylationT cellstherapeutic

Identifiers

PMID29740453
PMCPMC5928134
OpenAlexW2800959422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.